NVAX aims for $200
Updated
NVAX COVID vaccines will soon start Stage 3 clinical trial and the expecting result will be very promising.
Comment
Pre market: 202.3
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.